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Introduction: Therapeutic hypothermia (TH) is often used to treat out-of-hospital cardiac arrest (OHCA) patients
who also often simultaneously receive insulin for stress-induced hyperglycaemia. However, the impact of TH on
systemic metabolism and insulin resistance in critical illness is unknown. This study analyses the impact of TH on
metabolism, including the evolution of insulin sensitivity (SI) and its variability, in patients with coma after OHCA.
Methods: This study uses a clinically validated, model-based measure of SI. Insulin sensitivity was identified hourly
using retrospective data from 200 post-cardiac arrest patients (8,522 hours) treated with TH, shortly after admission to
the intensive care unit (ICU). Blood glucose and body temperature readings were taken every one to two hours. Data
were divided into three periods: 1) cool (T <35°C); 2) an idle period of two hours as normothermia was re-established;
and 3) warm (T >37°C). A maximum of 24 hours each for the cool and warm periods was considered. The impact of
each condition on SI is analysed per cohort and per patient for both level and hour-to-hour variability, between periods
and in six-hour blocks.
Results: Cohort and per-patient median SI levels increase consistently by 35% to 70% and 26% to 59% (P <0.001)
respectively from cool to warm. Conversely, cohort and per-patient SI variability decreased by 11.1% to 33.6% (P <0.001)
for the first 12 hours of treatment. However, SI variability increases between the 18th and 30th hours over the cool to
warm transition, before continuing to decrease afterward.
Conclusions: OCHA patients treated with TH have significantly lower and more variable SI during the cool period,
compared to the later warm period. As treatment continues, SI level rises, and variability decreases consistently except
for a large, significant increase during the cool to warm transition. These results demonstrate increased resistance to
insulin during mild induced hypothermia. Our study might have important implications for glycaemic control during
targeted temperature management.Introduction
Hyperglycaemia is prevalent in critical care [1-4] and
increases the risks of further complications and mortality
[1,4,5]. Glycaemic control has shown benefits in reducing
mortality and morbidity [4,6,7]. However, many studies
have found it difficult to reproduce these results [8-10]
due in part to metabolic variability [11]. Out-of-hospital
cardiac arrest (OHCA) patients often experience hypergly-
caemia [12,13]. These patients belong to one group who* Correspondence: chris.pretty@canterbury.ac.nz
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unless otherwise stated.can be highly insulin resistant and variable, particularly on
the first two days of stay [14], as well as those who may
particularly benefit from glycaemic control [4].
Therapeutic hypothermia (TH) is often used with OHCA
patients to protect against brain injury [15,16], which leads
to a lowering of metabolic rate, reduces plasma insulin, in-
duces insulin resistance and alters blood glucose homeo-
stasis [17]. One of the adverse events associated with
hypothermic therapy is a decrease in insulin sensitivity
and endogenous insulin secretion [18]. However, this de-
crease may not be observable in a cohort who is already
highly insulin resistant and variable [14]. Hence, under-
standing metabolic evolution and variability would enableLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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this cohort. This study analyses the evolution of a clinically
validated model-based measure of insulin sensitivity (SI) in
OHCA patients to assess the impact of hypothermia
therapy.
Methods
Patients and data
A retrospective analysis of glycaemic control data from
200 OHCA patients (8,522 hours) treated with TH,
shortly after admission to intensive care. Data was ob-
tained from intensive care units (ICUs) at Christchurch
Hospital, New Zealand, at Erasme Hospital, Belgium, and
CHUV-Lausanne Hospital, Switzerland. Patients from
Christchurch Hospital (N = 20) were on the specialized
relative insulin and nutrition titration (SPRINT) glycaemic
control protocol [7], whereas the remaining 180 patients
from Erasme (N = 99) and Lausanne (N = 81) hospitals
were on local glycaemic control protocols and included in
an institutional database (2008 to 2012).
Blood glucose (BG) and temperature readings were
taken one to two hourly. Data were divided into three
periods: 1) cool (T <35°C); 2) an idle period of two hours
as normothermia was restored; and 3) warm (T >37°C). A
maximum of 24 contiguous hours and a minimum of
15 hours for each period were considered, ensuring a
balance of contiguous data between periods. Overall
demographics are shown in Table 1.
Glycaemic targets while treating OHCA patients in the
three units were very similar and overlapped. The
SPRINT protocol, used in the Christchurch Hospital
ICU, targeted 4.0 to 7.0 mmol/L [7]. The protocol used
in both the Erasme and Lausanne ICUs differed from
SPRINT, but targeted 6.0 to 8.0 mmol/L [17]. Although
two different protocols were used in the three units, the
targets were very similar and within the relatively tight
4.0 to 8.0 mmol/L range.Table 1 Demographic data and treatment information for
both the cool and warm periods
Variables Value
Cool Warm
Total patients, number (n) 200
Median age, years 61 [51, 72]
Female gender, number (%) 40 (20.6%)
ICU mortality, number (%) 85 (45.6%)
Diabetes status, number (%) 26 (13.0%)
Total treatment, hours (h) 4219 4303
Blood glucose, median (mmol/L) 7.6 [6.3,9.7] 6.8 [5.9,8.0]
Insulin rate, median (U/hr) 3.4 [1.3,8.0] 3.5 [1.6,7.0]
Glucose rate, median (g/hr) 2.7 [1.0,5.3] 5.4 [2.7,8.1]
IQR: [interquartile range].Audit of the clinical data from SPRINT was given by
the Upper South B Regional Ethics Committee and for
the data study by Taccone et al. [17]. No approval was
required as it was also a retrospective audit.
Model-based insulin sensitivity
Model-based SI in this study is a patient-specific param-
eter describing the overall whole-body effect of insulin.
SI is identified for each hour, for each patient using a
clinically validated glucose-insulin model [19-23]. The
key model equations are defined:
_G ¼ −pG:G tð Þ−SI tð Þ:G tð Þ:
Q tð Þ
1þ αGQ tð Þ þ
P tð Þ þ EGP−CNS
VG
ð1Þ
_I ¼ −nK I tð Þ− nLI tð Þ1þ αI I tð Þ−nI I tð Þ−Q tð Þð Þ þ
uex tð Þ
VI
þ 1−XLð Þ uen tð ÞV I
ð2Þ
_Q ¼ nI I tð Þ−Q tð Þð Þ−nC Q tð Þ1þ αGQ tð Þ ð3Þ
Where G(t) represents the concentration of blood glu-
cose (mmol/L). I(t) and Q(t) represent the plasma insulin
and insulin interstitial concentrations (mU/L) respectively.
Model parameters, rates and constants in this model were
as fully defined in [21,24].
Model-based SI is identified hourly from patient data,
producing an hourly piece-wise constant profile [25],
capturing the whole-body glycaemic response to exogen-
ous insulin and nutrition. The validity and independence
of this patient-specific parameter have been validated
using data from independent, clinically matched cohorts
[19], in comparison to gold-standard insulin sensitivity
tests [22] and in clinical glycaemic control [20,23].
Analyses and metrics
SI level and variability during the cool (T ≤35°C) and
warm (T >35°C) periods are analysed on per-cohort and
per-patient bases using six-hour blocks of data as per
Table 2. SI level is compared between blocks as a cohort
median and by per-patient median SI. Similarly, SI variabil-
ity is calculated as the hour-to-hour percentage change in
SI (Δ%SI) and is analysed per cohort for each block.
%ΔSI ¼ SInþ1−SIn
 
SIn
 100 ð4Þ
The use of percentage change, rather than absolute
change, normalises the metric so patients with differing
SI levels can be compared fairly.
Table 2 Descriptions of six-hour blocks for data analysis
Day Period Analysis Block Hour range
1 Cool 6-hour block 1 0 – 6 hours
2 6 – 12 hours
3 12 – 18 hours
4 18 – 24 hours
Idle 2-hour period in between cool and warm
2 Warm 6-hour block 5 24 – 30 hours
6 30 – 36 hours
7 36 – 42 hours
8 42 – 48 hours
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both hypoglycaemia and BG variability with mortality
during the first 24 hours of ICU stay. Thus, the acute
evolution of SI over the first day using six-hour blocks
was analysed as SI variability is a key contributor to BG
variability. For the cohort analysis, SI and Δ%SI data
from all patients was grouped into each appropriate time
block. Median values for each time block were calculated
for comparison to the previous block, thus capturing
overall cohort changes over time in level and hour-
to-hour variability.
For the per-patient analysis, the median value of SI and
the interquartile range (IQR) of Δ% SI were calculated for
each patient, for each time block. The IQR captures the
width or degree of variability for a given patient withinFigure 1 Insulin sensitivity (SI) level distribution per cohort for out-of
hypothermia (TH) using six-hour blocks for both cool and warm perioeach six-hour block. Thus, a reduction in the IQR of Δ%
SI over time would indicate a reduction in hour-to-hour
variability for a given patient.
SI level and variability are non-Gaussian and thus com-
pared using non-parametric statistics and cumulative dis-
tribution functions (CDFs). CDFs are particularly useful as
they show the entire distribution that is often summarised
as a median and IQR. The CDF for a given value of the
independent variable (for example SI = x) describes the
probability of observing a value less than or equal to x. All
distributed data were compared using a Wilcoxon rank-
sum test (Mann–Whitney U test), except for SI variability
results. SI variability was compared using the Kolmogorov-
Smirnov (KS) test as it has greater power to detect differ-
ences in the shape of distributions when median values are
similar. In all cases, P <0.05 is considered statistically
significant.Results
SI level analyses
Figures 1 and 2 present the CDFs of hourly SI level by
cohort and median SI per patient, respectively, using
six-hour blocks. Table 3 presents the increase in median
insulin sensitivity and corresponding P values between
successive time blocks.
The results suggest that SI increases for the cohort
and per patient are statistically significant for the first
36 hours (P <0.05) in both cases.-hospital cardiac arrest (OHCA) patients, treated with therapeutic
ds.
Figure 2 Insulin sensitivity (SI) level distribution per patient for out-of-hospital cardiac arrest (OHCA) patients, treated with therapeutic
hypothermia (TH) using six-hour blocks for both cool and warm periods.
Table 3 Increasing cohort and per-patient median SI
during cool and warm periods as per six-hour blocks of
data, where the P values compare successive six-hour
blocks as shown in the first column for both the overall
cohort and per-patient median values
SI level Cohort analysis Per-patient analysis
analysis % SI median
increase
P value % SI median
increase
P value
(6-hr blocks)
Block 1–2 (C) 35.1 <0.05 26.4 <0.05
(0–6 vs. 6–12 hr)
Block 2–3 (C) 19.2 <0.05 31.1 <0.05
(6–12 vs. 12–18 hr)
Block 3–4 (C) 31.8 <0.05 42.4 <0.05
(12–18 vs. 18–24 hr)
Block 4–5 (C-W) 23.4 <0.05 18.3 <0.05
(18–24 vs. 24–30 hr)
Block 5–6 (W) 23.9 <0.05 23.2 <0.05
(24–30 vs. 30–36 hr)
Block 6–7 (W) 13.1 0.06 15.8 0.2
(30–36 vs. 36–42 hr)
Block 7–8 (W) 4.4 0.4 3.2 0.5
(36–42 vs. 42–48 hr)
P values are calculated using Wilcoxon rank-sum test. SI, insulin sensitivity
metric (model-based).
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reflected in Table 4, which shows that SI increases for a
large proportion of patients between the six-hour blocks
over the first 36 hours of ICU stay. Table 4 also shows
that after 48 hours of treatment, only 86% of patients
show rise in SI from the first six hours. Thus, while the
general trend is obvious for increasing SI, it is not guar-
anteed for all patients. Equally, these increases decelerate
in terms of number of patients with increasing SI over
time, going from left to right in the table.
SI variability analyses
Figures 3 and 4 present the CDFs for changes in SI
(%ΔSI) for six-hourly blocks per cohort and 50% range
of SI variability per patient, respectively. Table 5 presents
the reductions between successive blocks.
Cohort and per-patient variability decreases for the
first 24 hours. However, it increases across the cool to
warm transition, indicating some potential stress across
the cool to warm transition with negative reductions.
The decreasing trend returns for all subsequent blocks.
The results suggest that %ΔSI decreases per cohort and
per patient are statistically significant (P <0.05) for the
first 36 hours in both cases.
Discussion
Insulin sensitivity level
The SI level results for both per-cohort and per-patient
analysis suggest that OHCA patients undergoing TH
treatment have significantly lower SI during the earlier
Figure 3 Insulin sensitivity variability distribution (%ΔSI) per cohort for out-of-hospital cardiac arrest (OHCA) patients, treated with
therapeutic hypothermia (TH) using six-hour blocks for both cool and warm periods.
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Both results determine the general trend for overall in-
creasing SI level for critically ill patients over time and are
consistent with other ICU studies [14,27]. Further analysis
shows that the increase in SI level during the first 36 hours
are large and statistically significant for this cohort. The
rapid increases in SI level for the first 36 hours is likely
due to significant restart of human physiological systems
and metabolic activities for these patients [13]. After
36 hours, the rapid SI increase abates as the patients’
metabolism improves and becomes more stable.
Insulin sensitivity variability
Both per-cohort and per-patient analysis suggest that
OHCA patients undergoing TH treatment have high
initial variability that decreases over the first 36 hours.Table 4 Proportion of patients for whom median insulin sens
and columns
6 -12 hr 12-18 hr 18-24 hr
0 – 6 hr 0.72 0.74 0.79
6 – 12 hr 0.66 0.72
12 – 18 hr 0.69
18 – 24 hr
24 – 30 hr
30 – 36 hr
36 – 42 hrHowever, the cool to warm transition at 24 hours shows
an increase in variability likely due to the change of
physiological conditions as body temperature increases
from cool to warm between 18 and 36 hours. The lower
decrease in SI variability after the 36th hour onward
suggests that the patients’ metabolic condition has im-
proved and become more stable.
Further analysis and comparison of SI variability
between general ICU patients [14] and OHCA patients
treated with TH shows that the main difference between
them is the SI variability increase during the cool to warm
transition period for the latter cohort. These SI variability
results do not follow the same trend with other general
ICU studies by Pretty et al. [14], and it is a unique finding
for this cohort that could significantly impact glycaemic
control and safety from hypoglycaemia.itivity increases between the blocks indicated in the row
24-30 hr 30-36 hr 36-42 hr 42-48 hr
0.83 0.84 0.85 0.86
0.74 0.76 0.82 0.82
0.70 0.75 0.79 0.79
0.66 0.65 0.70 0.72
0.64 0.68 0.66
0.58 0.61
0.52
Figure 4 Per-patient 50% range of SI variability distribution of out-of-hospital cardiac arrest (OHCA) patients, treated with therapeutic
hypothermia (TH) using six-hour blocks for both cool and warm periods.
Table 5 Reductions in the interquartile range and median
SI per patient range of hour-to-hour percentage SI change
over time during cool and warm periods as per six-hour
blocks of data, where the P values compare successive
six-hour blocks as shown in the first column for both the
overall cohort and per-patient median values
SI variability Cohort analysis Per-patient analysis
analysis % reduction
of IQR
P value % median
decrease
P value
[6-hr blocks]
Block 1–2 (C) 11.1 <0.05 33.6 <0.05
(0–6 vs. 6–12 hr)
Block 2–3 (C) 20.7 <0.05 15.8 <0.05
(6–12 vs. 12–18 hr)
Block 3–4 (C) 14.4 <0.05 22.6 <0.05
(12–18 vs. 18–24 hr)
Block 4–5 (C-W) −19.7 <0.05 −14.9 <0.05
(18–24 vs. 24–30 hr)
Block 5–6 (W) 23.1 <0.05 26.4 0.05
(24–30 vs. 30–36 hr)
Block 6–7 (W) 4.6 <0.05 0.8 0.05
(30–36 vs. 36–42 hr)
Block 7–8 (W) 13.0 0.08 17.1 0.06
(36–42 vs. 42–48 hr)
P values are calculated using the Kolmogorov-Smirnov test. SI, insulin sensitivity
metric (model-based); IQR, interquartile range.
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Clinically, these results have significant implications for
managing glycaemia. Increased SI variability leads to
increased variability in BG level for a given insulin inter-
vention [11]. With low and variable insulin sensitivity,
glycaemic levels might appear to remain unchanged and
difficult to control effectively with exogenous insulin.
This situation may result in increased glycaemic variabil-
ity as well as an increased risk of hyperglycaemia and
hypoglycaemia during the first 36 hours of treatment
due to greater hour-to-hour SI variability with increased
insulin resistance [17]. Thus, since glycaemic variability
and hypoglycaemia are independent risk factors for the
critically ill, it is important to understand and manage
these patient-specific dynamics, especially those unique
to a cohort, when implementing glycaemic control. This
outcome is particularly important when OHCA patients
transition from cool to warm. These results may also
generalise to other areas where glycaemic control is
applied to hypothermic patients, such as in the operating
theatre.
There are several ways that this low and variable insulin
sensitivity could be managed during glycaemic control. Re-
ducing exogenous insulin doses, coupled with modulation
of the glucose content of nutrition would diminish the im-
pact of sudden changes of insulin sensitivity on glycaemic
outcome. Equally, increased BG measurement frequency
could improve control and reduce glycaemic variability.
Accepting higher glycaemic targets during periods of
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hypoglycaemia against increased hyperglycaemia. Ultim-
ately, the preferred method for any unit may be influenced
by practical considerations, such as clinical workload.Limitations
The parameters used in the glucose insulin system model
are based on general ICU patients with normal body
temperature conditions. Thus, the insulin sensitivity values
derived during the cool period could be biased by model-
ling errors or unmodelled effects. However, as noted previ-
ously, the validity and independence of this patient-specific
parameter has been validated using data from clinically
matched cohorts and has been shown to correlate well in
gold-standard insulin sensitivity tests.
Insulin sensitivity variability is a key contributor to gly-
caemic variability. Sechterberger et al. [28] showed an as-
sociation between high glycaemic variability and mortality
is not present in diabetic cohorts. Thus, a subgroup ana-
lysis of diabetic OHCA patients in this study would be
very interesting. However, only 26 of 200 (13%) OHCA
patients in this study had previously diagnosed diabetes
(Table 1), which is too few to enable a reliable analysis
with these methods. Additionally, in this particular cohort,
undiagnosed diabetes or impaired glucose regulation [29]
may confound such a subgroup.Conclusions
This study analyses the metabolic evolution of OHCA
patients treated with TH. These analyses characterise the
metabolic impact of TH treatment on the level and vari-
ability of insulin sensitivity to inform control.
Two main conclusions are drawn as a result for these
cohorts.
i) SI level is much lower during TH and consistently
increases over time, during both cool and warm
periods.
ii) Insulin sensitivity is more variable during the cool
period and shows contrasting behaviour during the
cool to warm transition period between 18 and
30 hours, which indicates that there are major
changes in physiology and metabolic conditions
between cool and warm as influenced by human
body temperature. Otherwise, it decreases over time.
Finally, this study shows the need for patient-specific
glycaemic management to ensure good control and
safety during treatment. These results have significant
potential clinical impact on the metabolic treatment of
these patients, and changes in clinical therapy are re-
quired to safely treat patients as they transition from
cool to warm.Key messages
 OCHA patients treated with TH have significantly
lower and highly variable SI during the first 24 hours
of the cool period, compared to the later warm
period in their ICU stay.
 There is an overall trend of increasing SI over the
first 36 hours, both per-cohort and per-patient
results.
 SI variability decreases consistently over time, except
for a large, statistically significant increase during
the cool to warm transition at 24 hours.
 This increase requires special consideration for
glycaemic control as it increases risk of
hypoglycaemia, BG variability and thus mortality.
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